Evaluation of a Belatacept-Based Immunosuppression Regimen in Kidney Transplant Recipients

被引：0
|
作者：
Brisku, R. [1 ]
Rudzik, K. [1 ]
Augustine, J. [2 ]
Eckardt, J. [1 ]
机构：
[1] Cleveland Clin, Pharm, Cleveland, OH 44106 USA
[2] Cleveland Clin, Nephrol, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B209
引用
收藏
页码：S848 / S849
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [22] Outcomes of de novo belatacept-based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization
    Petrossian, Gregory
    Ortiz, Jorge
    Ortiz, Alejandro Chiodo
    Koizumi, Naoru
    Plews, Robert
    NEPHROLOGY, 2022, 27 (12) : 1006 - 1007
  • [23] Outcomes of de novo belatacept-based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization
    Patel, Ankita
    Shertel, Tara
    Wynd, Michael
    Wadhera, Vikram
    Serur, David
    Schleich, Benjamin
    Yushkov, Yuriy
    Goldstein, Michael
    NEPHROLOGY, 2022, 27 (11) : 901 - 905
  • [24] Belatacept-Based Immunosuppression in Heart Transplant Recipients: National Trends with Outcomes from a Single Center
    Magua, W.
    Okoh, A. K.
    Pranav, P.
    Wang, J.
    Karadkhele, G.
    Cole, R.
    Daneshmand, M.
    Gupta, D.
    Larsen, C.
    Morris, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S248 - S248
  • [25] Conversion to Belatacept-Based Immunosuppression Therapy in Renal Transplant Patients
    Paz, M.
    Roberti, J.
    Mos, F.
    Cicora, F.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 2987 - 2990
  • [26] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    TRANSPLANTATION, 2014, 98 : 456 - 456
  • [27] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 456 - 456
  • [28] Donor- Derived Cell- Free Dna Surveillance in Kidney Transplant Recipients Receiving Belatacept-Based Maintenance Immunosuppression
    Loarte, P.
    Miles, J.
    Lewis, Z. Stewart
    Ali, N. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S984 - S985
  • [29] Belatacept-based therapy cost effective in kidney transplant
    Reactions Weekly, 2013, 1455 (1) : 3 - 3
  • [30] Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned
    Saidi, R.
    Huang, N.
    Yang, C.
    Movileanu, I.
    Ecal, K.
    Senay, A.
    Pankewycz, O.
    Dvorai, R.
    Shahbazov, R.
    Laftavi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 432 - 432
12345